IFS Advisors’s Gilead Sciences GILD Stock Holding History

IFS Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.13K	Hold	24	–	–	﹤0.01%	172
2026 Q1	$3.43K	Hold	24	–	–	﹤0.01%	162
2025 Q4	$3K	Hold	24	–	–	﹤0.01%	146
2025 Q3	$2.7K	Hold	24	–	–	﹤0.01%	140
2025 Q2	$2.68K	Buy	24 +1	+4%	+$106	﹤0.01%	133
2025 Q1	$2.69K	Hold	23	–	–	﹤0.01%	153
2024 Q4	$2.2K	Hold	23	–	–	﹤0.01%	145
2024 Q3	$1.98K	Hold	23	–	–	﹤0.01%	124
2024 Q2	$1.6K	Hold	23	–	–	﹤0.01%	122
2024 Q1	$1.69K	Buy	23 +1	+5%	+$77	﹤0.01%	120
2023 Q4	$1.85K	Hold	22	–	–	﹤0.01%	114
2023 Q3	$1.7K	Hold	22	–	–	﹤0.01%	111
2023 Q2	$1.73K	Hold	22	–	–	﹤0.01%	108
2023 Q1	$1.84K	Hold	22	–	–	0.01%	84
2022 Q4	$1.89K	Buy	22 +1	+5%	+$79	﹤0.01%	93
2022 Q3	$1K	Hold	21	–	–	﹤0.01%	91
2022 Q2	$1K	Hold	21	–	–	﹤0.01%	91
2022 Q1	$1K	Hold	21	–	–	﹤0.01%	101
2021 Q4	$1K	Buy	+21	New	+$1.45K	﹤0.01%	108
2021 Q1	–	Sell	-20	Closed	-$1K	–	65
2020 Q4	$1K	Buy	+20	New	+$1.21K	﹤0.01%	155

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IFS Advisors's GILD Position: Q2 2026 in Review

IFS Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 24 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #172.

IFS Advisors first reported a position in GILD in Q4 2020 and has held it in 20 quarters since. The position peaked at $3.43K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

IFS Advisors held 24 shares of Gilead Sciences worth $3.13K as of Q2 2026.
IFS Advisors left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up ﹤0.01% of IFS Advisors's portfolio in Q2 2026, its #172 holding.
IFS Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 20 quarters since.
IFS Advisors's Gilead Sciences position peaked at $3.43K in Q1 2026.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on IFS Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.